Tag: favorable
RELX PLC: JPMorgan favorable on the file
Marketzone with MT Newswires 2022 All the news on RELX PLC RELX PLC analyst recommendations Financial data GBPUSDUSD 2022…
Innate Pharma: clinical activity and favorable safety profile of lacutamab – 09/23/2022 at 08:54
(AOF) – Innate Pharma announced that its anti-KIR3DL2 antibody, lacutamab, has established clinical responses in patients with mycosis fungoides in the Phase 2 Tellomak trial. “Therapeutic options are limited for…
Sanofi: European favorable opinion for Enjaymo
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Sanofi: European favorable opinion for Enjaymo – 09/16/2022 at 16:21
(CercleFinance.com) – The Scientific Committee of the European Medicines Agency (EMA) yesterday issued a favorable opinion concerning the granting of a marketing authorization for Enjaymo, Sanofi’s treatment for patients with…
Capital One Financial Corporation: Citigroup favorable on the file
Marketzone with MT Newswires 2022 All the news on CAPITAL ONE FINANCIAL CORPORATION Analyst recommendations on CAPITAL ONE FINANCIAL CORPORATION …
Cross Country Healthcare, Inc.: Barrington Research favorable on the file
Marketzone with MT Newswires 2022 All the news on CROSS COUNTRY HEALTHCARE, INC. 09/15 CROSS COUNTRY HEALTHCARE, INC. : Barrington Research favorable…
NEW WORK: Hauck & Aufhauser favorable on the file
In a research note published by Nicole Winkler, the broker Hauck & Aufhauser advises taking an interest in the stock with a…
KLÖCKNER & CO: Jefferies favorable on the file
In a research note published by Alan Spence, the broker Jefferies advises to be interested in the title with an opinion on…
AstraZeneca: Favorable data in ovarian cancer
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
FLUTTER: Barclays favorable on the file
James Rowland Clark of Barclays sees the stock as a buying opportunity. The target price is unchanged at 13800 GBX. Zonebourse with…
Sanofi: Favorable data in pediatric asthma
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Sanofi: favorable data in pediatric asthma – 09/05/2022 at 09:40
(CercleFinance.com) – Sanofi announced on Monday that new data on Dupixent have revealed a “homogeneous” long-term safety and efficacy profile in pediatric asthma. These results, from the extension phase of…